Treatment Augmentation Effects of EMDR Intervention after Traumatic Experiences in Patients with Major Depression: a Case Series

Majör depresyon hastalarında travmatik yaşantılar sonrası EMDR uygulamasının tedaviyi güçlendirici etkileri: Olgu serisi. Depresyon yineleyici ve süregen bir süreci olan mortalite ve morbidite açısından ciddi sonuçlara yol açabilen yaygın bir bozukluktur. Depresyon hastalarının yaklaşık yarısının ilk tedaviye yanıtı yetersiz olmakla birlikte hastaların %20'si herhangi bir ilaçtan fayda görmemektedir. Bu yazı depresyon tanısıyla ilaç tedavisi alan üç hastanın göz hareketleri ile duyarsızlaştırma ve yeniden işleme (EMDR) müdahalesi ile şikayetlerindeki değişimi anlatmaktadır. 28-44 yaş aralığında üç kadın depresyon hastasına EMDR uygulanmıştır. İki hastanın ilaç tedavisi venlafaksin 150mg/gün ve mirtazapin 30mg/gün, diğer hastanın ilaç tedavisi ise bupropion 300mg/gün ve mirtazapin 30mg/gün idi. Hastalara 6-8 seans EMDR uygulanmıştır. Hastaların travmatik yaşam olayları çalışılmıştır. Hastalara EMDR öncesi ve sonrası olmak üzere iki defa Beck Depresyon Envanteri (BDE), Beck Anksiyete Envanteri (BAE) ve Durumluluk-Süreklilik Kaygı Ölçeği (DSKÖ) doldurtuldu. EMDR terapisi sonrası üç hastada da BDE, BAE ve DSKÖ puanlarında önemli düzeyde azalma saptandı. Bu yazıda depresyon hastalarına EMDR ile müdahale edilmesinin yararlı olduğu gösterilmiştir.

Majör depresyon hastalarında travmatik yaşantılar sonrası EMDR uygulamasının tedaviyi güçlendirici etkileri: Olgu serisi

Treatment augmentation effects of EMDR intervention after traumatic experiences in patients with major depression: a case series. Depression is a frequent disorder that may have a recurring and chronic course with a potentially serious impact on morbidity and mortality. While around half of the patients show an inadequate response to initial antidepressant therapy, as many as 20% of patients with chronic depression do not benefit from any other alternative drugs. In this case series, three patients diagnosed with depression were treated with Eye Movement Desensitization and Reprocessing (EMDR). Three women (aged 28-44 years) diagnosed with depression were admitted to EMDR therapy. All patients actually underwent antidepressant treatment. Two patients received 150mg/day venlafaxine and mirtazapine, one patient 300mg/day bupropion and 30mg/day mirtazapine. Six to eight sessions of EMDR were applied to the patients. Before and after treatment, patients completed Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and StateTrait Anxiety Inventory (STAI). After treatment, there was a statistically significant reduction in patientreported BDI, BAI, and STAI scores. EMDR therapy augmentation was effective in the treatment of patients with depression.

PDF

___

Unal S, Ozcan ME. Precipitating, predisposing and protective factors in depression. Anatolian Journal of Psychiatry 2000; 1:41- 47. (Turkish)
Yazici O. Treatment resistant depression. Bulletin of Clinical Psychopharmacology 1999; 9:68-77. (Turkish)
Cetin M. The place of atypical antipsychotics in treatment- resistant depressions. Bulletin of Clinical Psychopharmacology 2010; 20 (Suppl.1):15-25.
Kavakci O, Dogan O, Kugu N. EMDR (eye movement desensitization and reprocessing): a different option in psychotherapy. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2010; 23:195-205. [CrossRef]
Kavakci O, Yenicesu GI. Eye movement desensitization and reprocessing (EMDR) for hyperemesis gravidarum: a case series. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2014; 27:335-341. [CrossRef]
Bae H, Kim D, Park YC. Eye movement desensitization and reprocessing for adolescent depression. Psychiatry Investig 2008; 5:60-65. [CrossRef]
Hase M, Balmaceda UM, Hase A, Lehnung M, Tumani V, Huchzermeier C, Hofmann A. Eye movement desensitization and reprocessing (EMDR) therapy in the treatment of depression: a matched pairs study in an inpatient setting. Brain Behav 2015; 5:1-9. [CrossRef]
Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000; 320:26-30. [CrossRef]
Mohr DC, Ho J, Hart TL, Baron KG, Berendsen M, Beckner V, Cai X, Cuijpers P, Spring B, Kinsinger SW, Schroder KE, Duffecy J. Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Transl Behav Med 2014; 4:407- 423. [CrossRef]
Bilican FI, Soygut G. Professional development processes of trainee and experienced psychotherapists in Turkey. Turk Psikiyatri Derg 2015; 26:249-260. (Turkish) [CrossRef]
van Hees ML, Rotter T, Ellermann T, Evers SM. The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review. BMC Psychiatry 2013; 13:22. [CrossRef]
van der Velden AM, Kuyken W, Wattar U, Crane C, Pallesen KJ, Dahlgaard J, Fjorback LO, Piet J. A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder. Clin Psychol Rev 2015; 37:26-39. [CrossRef]
Shapiro F. Eye Movement Desensitization and Reprocessing: Basic Principles, Protocols and Procedures. New York: Guilford Press 2001.
Shapiro F. The role of eye movement desensitization and reprocessing (EMDR) therapy in medicine: addressing the psychological and physical symptoms stemming from adverse life experiences. Perm J 2014; 18: 71-77. [CrossRef]
McGuire TM, Lee CW, Drummond PD. Potential of eye movement desensitization and reprocessing therapy in the treatment of post-traumatic stress disorder. Psychol Res Behav Manag 2014; 7:273-283.
Vitriol V, Cancino A, Weil K, Salgado C, Asenjo MA, Potthoff S. Depression and psychological trauma: an overview integrating current research and specific evidence of studies in the treatment of depression in public mental health services in Chile. Depress Res Treat 2014; 608671. [CrossRef]
Bockting CL, Hollon SD, Jarrett RB, Kuyken W, Dobson K. A lifetime approach to major depressive disorder: the contributions of psychological interventions in preventing relapse and recurrence. Clin Psychol Rev 2015; 41:16-26. [CrossRef]